Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy
F Skoulidis, JV Heymach�- Nature Reviews Cancer, 2019 - nature.com
The impressive clinical activity of small-molecule receptor tyrosine kinase inhibitors for
oncogene-addicted subgroups of non-small-cell lung cancer (for example, those driven by�…
oncogene-addicted subgroups of non-small-cell lung cancer (for example, those driven by�…
Non-small-cell lung cancers: a heterogeneous set of diseases
Z Chen, CM Fillmore, PS Hammerman, CF Kim…�- Nature Reviews�…, 2014 - nature.com
Non-small-cell lung cancers (NSCLCs), the most common lung cancers, are known to have
diverse pathological features. During the past decade, in-depth analyses of lung cancer�…
diverse pathological features. During the past decade, in-depth analyses of lung cancer�…
[HTML][HTML] Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer
Background Human epidermal growth factor receptor 2 (HER2)–targeted therapies have not
been approved for patients with non–small-cell lung cancer (NSCLC). The efficacy and�…
been approved for patients with non–small-cell lung cancer (NSCLC). The efficacy and�…
[HTML][HTML] Comprehensive molecular profiling of lung adenocarcinoma
Cancer Genome Atlas Research Network�- Nature, 2014 - ncbi.nlm.nih.gov
Adenocarcinoma of the lung is the leading cause of cancer death worldwide. Here we report
molecular profiling of 230 resected lung adenocarcinomas using messenger RNA�…
molecular profiling of 230 resected lung adenocarcinomas using messenger RNA�…
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
AM Newman, SV Bratman, J To, JF Wynne…�- Nature medicine, 2014 - nature.com
Circulating tumor DNA (ctDNA) is a promising biomarker for noninvasive assessment of
cancer burden, but existing ctDNA detection methods have insufficient sensitivity or patient�…
cancer burden, but existing ctDNA detection methods have insufficient sensitivity or patient�…
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network Tissue�…�- Nature, 2008 - nature.com
Human cancer cells typically harbour multiple chromosomal aberrations, nucleotide
substitutions and epigenetic modifications that drive malignant transformation. The Cancer�…
substitutions and epigenetic modifications that drive malignant transformation. The Cancer�…
Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications
N Iqbal, N Iqbal�- Molecular biology international, 2014 - Wiley Online Library
Human epidermal growth factor receptor 2 (HER2) is a member of the epidermal growth
factor receptor family having tyrosine kinase activity. Dimerization of the receptor results in�…
factor receptor family having tyrosine kinase activity. Dimerization of the receptor results in�…
Understanding and targeting resistance mechanisms in NSCLC
J Rotow, TG Bivona�- Nature Reviews Cancer, 2017 - nature.com
The expanding spectrum of both established and candidate oncogenic driver mutations
identified in non-small-cell lung cancer (NSCLC), coupled with the increasing number of�…
identified in non-small-cell lung cancer (NSCLC), coupled with the increasing number of�…
The cancer genome
MR Stratton, PJ Campbell, PA Futreal�- Nature, 2009 - nature.com
All cancers arise as a result of changes that have occurred in the DNA sequence of the
genomes of cancer cells. Over the past quarter of a century much has been learnt about�…
genomes of cancer cells. Over the past quarter of a century much has been learnt about�…
Autophagy in malignant transformation and cancer progression
Autophagy plays a key role in the maintenance of cellular homeostasis. In healthy cells,
such a homeostatic activity constitutes a robust barrier against malignant transformation�…
such a homeostatic activity constitutes a robust barrier against malignant transformation�…